NCT03516630View on ClinicalTrials.gov

Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

May 1, 2017

Study Completion Date

May 1, 2017

Conditions

Healthy

Interventions

DRUG

Trazodone 20 mg

Oral drops

DRUG

Trazodone 60 mg

Oral drops

DRUG

Trazodone 140 mg

Oral drops

DRUG

Placebo

Oral drops

DRUG

Moxifloxacin 400mg

Tablet

Trial Locations (1)

CH-6864

CROSS Research S.A., Phase I Unit,, Arzo

Sponsors

Collaborators (1)

Cross Research S.A.

All Listed Sponsors

collaborator

Cross Research S.A.

INDUSTRY

collaborator

eResearch Technology, Inc.

INDUSTRY

lead

Aziende Chimiche Riunite Angelini Francesco S.p.A

INDUSTRY